DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Nabeel Bardeesy, Taranjit S. Gujral et al.|Cancer Discovery|2024Cited by 14
Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic TargetsVindhya Vijay, Nabeel Bardeesy, Negin Karisani et al.|Cancer Discovery|2025Cited by 11
Data from DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Nabeel Bardeesy, Jinkai Wan et al.|Unknown|2025Cited by 3
Supplementary Figures S1-S8 from DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Nabeel Bardeesy, Jinkai Wan et al.|Unknown|2025Cited by 0
Correction: DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Nabeel Bardeesy, Jinkai Wan et al.|Cancer Discovery|2025Cited by 0